LifeScience Alley Announces New Appointments
News May 30, 2013
LifeScience Alley announces the election of the following officers to its board of directors: Kathleen Chester, vice president of global regulatory affairs and corporate officer, St. Jude Medical, Inc.; Todd Fruchterman, MD, PhD, senior vice president of research and development and regulatory affairs, chief technology officer and chief medical officer, 3M Health Care; Brian Herman, PhD, vice president for research, University of Minnesota; Rick Kuntz, MD, senior vice president for strategy and scientific operations, chief scientific, clinical and regulatory officer, Medtronic, Inc. and Jeff Mirviss, senior vice president and president, Peripheral Interventions, Boston Scientific Corporation. In addition, current board vice chair Stephen Snyder - vice president marketing, Cargill Industrial Oils & Lubricants - has been elected to serve as chairman of the board of directors. Outgoing chairman, Steve Mertens, senior vice president of operations, Holaira, Inc., has been elected to serve as vice chair.
"We are very excited to announce the addition of these officers to LifeScience Alley's board of directors," states Steve Mertens, outgoing chairman of the board. "As our organization continues to strengthen our impact on the national and international operating environment for our members, direction from thought leading individuals and organizations like these is critical."
The election of these high-level industry executives underscores the organization's strategic commitment to providing its members and community with expanded leadership and support at a critical time. Many sectors of the life sciences industries are undergoing economic and policy-based shifts directly affecting business innovation and growth. LifeScience Alley and its subsidiaries, in accordance with their mission, are focused on advocating for sound public policy and engaging in special projects to develop and grow the industries that will ensure Minnesota's leadership in the global life science ecosystem.
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE